CD247, a novel T cell-derived diagnostic and prognostic biomarker for detecting disease progression and severity in patients with type 2 diabetes.

scientific article published on 3 November 2014

CD247, a novel T cell-derived diagnostic and prognostic biomarker for detecting disease progression and severity in patients with type 2 diabetes. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DC14-1544
P698PubMed publication ID25368105

P50authorMoshe Sade-FeldmanQ83565273
P2093author name stringMichal Baniyash
Roy Eldor
Yair Klieger
Camil Fuchs
Ilan Vaknin
Inna Varfolomeev
P2860cites workGlycated hemoglobin measurement and prediction of cardiovascular diseaseQ34040328
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectbiomarkerQ864574
type 2 diabetesQ3025883
P304page(s)113-118
P577publication date2014-11-03
P1433published inDiabetes CareQ5270111
P1476titleCD247, a novel T cell-derived diagnostic and prognostic biomarker for detecting disease progression and severity in patients with type 2 diabetes
P478volume38

Reverse relations

cites work (P2860)
Q37553115An epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort
Q92738411Identification of key miRNA‑mRNA pairs in septic mice by bioinformatics analysis
Q39412983Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases.
Q26777205Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate
Q38966318Quantitative flow cytometry: Concerns and recommendations in clinic and research
Q57327813Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design

Search more.